H. Lundbeck A/S (Lundbeck) today announced the acceptance of its new drug application (NDA) for Vyepti® (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan.

Sudan's ongoing nationwide conflict has triggered one of the world's worst humanitarian crises, displacing 13·9 million people,1 including more than 4 million individuals who have fled across borders.

HELSINKI, Nov. 14, 2025 /PRNewswire/ -- Stora Enso today announces: ...

Self-administered hypnosis effectively alleviates hot flashes in menopausal women, enhancing quality of life and providing an ...